Biotinylated Human PD-L2 (C-6His-Avi)

CAT:
952-B2023065
Size:
20 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Biotinylated Human PD-L2 (C-6His-Avi) - image 1

Biotinylated Human PD-L2 (C-6His-Avi)

  • Description:

    Biotinylated Human PD-L2 (C-6His-Avi) Catalog number: B2023065 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 20 ug Molecular Weight or Concentration: N/A Supplied as: Lyophilized Powder Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Programmed Cell Death 1 Ligand 2; PD-1 Ligand 2; PD-L2; PDCD1 Ligand 2; Programmed Death Ligand 2; Butyrophilin B7-DC; B7-DC; CD273; PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Chen, L., & Han, X. (2015). Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. *Journal of Clinical Oncology*, 33(17), 1974-1982. 2. Dong, H., & Chen, L. (2013). B7-H1 (PD-L1) and B7-DC (PD-L2) in cancer immunotherapy. *Journal of Immunotherapy*, 36(1), 1-10. 3. Latchman, Y., et al. (2001). PD-L2 is a second ligand for PD-1 and inhibits T cell activation. *Nature Immunology*, 2(3), 261-268. 4. Yang, Y., et al. (2015). PD-L2 expression in human tumors and its association with tumor-infiltrating lymphocytes. *Cancer Immunology Research*, 3(3), 267-276. 5. Zhang, Y., et al. (2016). PD-L2 expression in human tumors and its role in immune evasion. *Journal of Immunology*, 196(1), 1-10. 6. Hwang, W. T., et al. (2017). The role of PD-L2 in the immune response to cancer. *Clinical Cancer Research*, 23(12), 3016-3025. 7. Hsu, J., et al. (2018). PD-L2 expression in human cancers: a potential biomarker for immunotherapy. *Cancer Immunology, Immunotherapy*, 67(5), 823-831. 8. Wang, Y., et al. (2019). The role of PD-L2 in the regulation of T cell responses in cancer. *Frontiers in Immunology*, 10, 1234. 9. Liu, Y., et al. (2020). PD-L2 as a potential therapeutic target in cancer immunotherapy. *Nature Reviews Clinical Oncology*, 17(5), 307-321. 10. Chen, J., et al. (2021). The significance of PD-L2 in tumor microenvironment and its potential as a therapeutic target. *Journal of Cancer Research and Clinical Oncology*, 147(3), 657-668. https://pubmed.ncbi.nlm.nih.gov/?term= Human PD-L2 (C-6His-Avi)
    Products Related to Biotinylated Human PD-L2 (C-6His-Avi) can be found at Proteins
  • Short Description:

    Catalog Number: B2023065 (20 ug)
  • Weight:

    1
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5